ABVX

#898
Abivax SA American Depositary Shares
125.80 USD
+3.70%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
125.80
125.80
Intervallo Annuale
5.59
148.83
Variazione giornaliera
+3.70%
Variazione Mensile
+4.83%
Variazione di 6 mesi
+28.09%
Variazione Annuale
+2017.85%
Chiusura Precedente
121.31
Apertura
125.80
Bid
Ask
Minimo
125.80
High
125.80
Volume
48
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 202320242025 TTM

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Notizie